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Background: Breast cancer is the leading cause of cancer deaths in Nigerian women. Most cases present in late or advanced 
stages with consequent poor prognosis. There are also instances of false clinical diagnoses with resultant patient adversity. 
Population screening based on genetics is largely unavailable to the citizens. Therefore, early diagnosis is the immediate choice 
available to the health system. 
Methods: Retrospective data were collected including all open-breast-biopsies submitted to three histopathology laboratories. The 
clinical and histologic diagnoses for each sample were compared. Statistical estimate of the accuracy of clinical diagnoses of 
breast cancer by clinicians was calculated using histologic diagnoses as the reference standard, and by calculating the sensitivity, 
specificity, false rates and odds ratio. Diagnostic accuracies of clinicians working in public and private hospitals were also 
compared in terms of these rates. 
Results: Our result showed that the diagnostic accuracy of the doctors working in public hospitals is more sensitive than that of 
those working in private hospitals. The overall false positive rate in both hospital groups combined is found to be high. This is 
probably due to unavailability of modern radiodiagnostic facilities that may otherwise enhance clinical assessment and diagnoses. 
The doctors in the public hospital group are generally more efficient in breast cancer diagnoses than those working in private 
hospitals. 
Conclusion: The authors believe that better funding of the audited hospitals, regular training of the medical personnel and 
provision of modern radiodiagnostic facilities may probably enhance clinical accuracy of breast cancer diagnoses in these 
hospitals. 
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Introduction 
Breast cancer is the leading female malignancy in the 
world and is believed to be the most common cancer among 
women in Nigeria [1-3]. 
Although the exact prevalence of breast cancer disease in 
Nigeria is not really known, the prevalence rate based on 
only hospital data is 116 per 100,000 population [3]. This 
rate is expected to be much higher in the general 
population. Due to the absence of systematic 
population-based cancer registration, most information has 
come from small clinical and pathology case series which 
suffer from serious under-reporting of cases resulting in 
inherent bias.  These hospital-based studies have 
consequently affected current understanding of the pattern 
and characteristics of breast cancer in Africa [4]. According 
to International Agency for Research on Cancer (IARC) data, 
the 5-year incidence and mortality rates of breast cancer in 
Nigeria are 18,935 (30.7%) and 10,469 (22.9%) per 100,000 
respectively [5]. 
In Nigeria patients with breast cancer disease are often 
associated with poor prognosis for a variety of reasons 
[6]. Usually, early diagnoses, properly planned and timely 
medical intervention coupled with follow-up as is the 
practice in industrialized societies is necessary to achieving a 
better outcome. These are in-turn dependent on education of 
population at risk and the general population, adequately 
trained health personnel, good medical facilities and a 
well-structured screening program, among other 
requirements which are still generally lacking in Nigeria.  
Histopathologic assessment of breast cancer has long 
provided the basis for diagnosis, prediction of recurrence risk 
and prescription of adjuvant therapy. Biopsy techniques vary 
in the level of invasiveness and amount of tissue sample, 
which affects yield and patient experience [7]. Of all biopsy 
methods, open biopsy although more invasive, often allows 
better gross-morphological assessment, specimen sampling 
and also offers a better setting for more accurate histologic 
diagnoses. Shyyan et al (2006) emphasized correlation 
between clinical breast examination (CBE) and imaging 
findings with pathologic findings. They further stated the 
need for a histopathologic diagnosis before initiating breast 
cancer treatment. Expertise in pathology therefore was 
reaffirmed to be a key requirement for ensuring reliable 
diagnostic findings [8]. 
Mammography is the standard of reference for the clinical 
detection of breast cancer and is expected to 
reasonably augment the clinical diagnostic accuracy. 
According to data from the Breast Cancer Detection 
Demonstration Project (1982), the false-negative rate of 
mammography is approximately 8%–10% [9].  Possible 
causes for missed breast cancers include dense parenchyma 
obscuring a lesion, poor positioning or technique, perception 
error, incorrect interpretation of a suspect finding, subtle 
features of malignancy, and slow growth of a lesion [10]. In 
another study, an assessment of the level of accuracy of 
clinical breast examination (CBE) for breast cancer 
diagnosis was carried out with a resultant false negative rate 
of 19% [11]. 
Errors related to delayed or erroneous diagnoses are 
frequent and is an under-reported cause of patient injury 
[12-15]. Apparently these errors seem to be more appreciated 
by malpractice lawyers particularly in the industrialized 
nations and more particularly in the United States of America. 
It is not uncommon to find these lawyers advertise their 
services on the internet to exploit these errors. 
Erroneous diagnoses of breast cancer is often a source of 
psycho-social trauma to both patient and family members; in 
the event breast cancer is truly present, missed diagnosis 
increases cost of cancer management and often result to poor 
treatment outcome. Analysis of large cohort study, showed 
that patients who had recently received a cancer diagnosis 
had increased risks of both suicide and death from 
cardiovascular causes, as compared with cancer-free persons 
[16]. This therefore beckons the need for diagnosticians to 
hone their skills to avoid the unnecessary untoward effects of 
false diagnoses. 
Published research estimating sensitivity, specificity, false 
rates and odds ratio of results of clinical diagnoses of breast 
cancer in Nigeria using histological diagnoses as the 
reference standard are not readily available. In this study we 
seek to statistically estimate the clinical diagnostic accuracy 
of breast cancer by clinicians using histologic diagnoses as 
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the reference standard by calculating the sensitivity, 
specificity, false rates and odds ratio. We also intend to 
compare the diagnostic accuracies of clinicians working in 
public with those working in private hospitals in terms of 
these rates.  
Methods 
Oyeka et al (2012;2013) [17,18] developed a method for 
assessing the strength of association of screening 
test results and state of nature or condition using odds ratio 
based on false rates, sensitivity and specificity of the test 
[19,20]. 
Oyeka et al (2013) further showed that the odds-ratio is 
equal to 1,     , when the screening test results and the 
existing condition are not in any way associated [18]. In 
which case the diagnostic test is unable to correctly screen a 
subject having the condition as actually having it, and the 
subject free of the condition as actually not having it. Thus 
the smaller the value of the odds ratio, ( ), the lower and 
weaker the association between the test results and state of 
nature; the greater or larger the value of the odds ratio ( ) the 
higher and stronger the association. The statistical 
significance of the estimated odds ratio ( ), if desired, is 
determined by the usual chi-square test for independence [19] 
using sample data.  
However, as the authors noted, if sample sizes are very 
large as in the present data, statistical tests for significance 
may not be very necessary since in these cases 
most  statistical tests tend to be significant [21,22]. In such 
cases, patterns and levels of results may be of greater interest 
and importance rather than merely statistical significance of 
results. This approach is adopted in this paper where 
emphasis is more on the interpretation of patterns and levels 
of differences in diagnostic results. 
The methodologies developed by Oyeka and others under 
reference are here used with some case studies respecting 
breast cancer among patients in Nigeria. 
Source and nature of data 
Retrospective data were collected including all 
open-breast-biopsies submitted to three histopathology 
laboratories in Anambra State, Eastern Nigeria. The three 
laboratories are histopathology laboratory of Nnamdi 
Azikiwe University Teaching Hospital, Nnewi and that of 
two privately owned laboratories, Pathocon Specialist Clinic 
and Research Institute, Nnewi and Nkeoma Specialist 
Hospital, Onitsha.  These laboratories are accredited by 
Anambra State Department of Hospital Services, while the 
Histopathologists that work in these laboratories are certified 
by the National College of Pathologists, Nigeria. 
The clinical diagnoses and corresponding histologic 
diagnoses were retrieved from pooled data from the three 
laboratories that were previously stored in SPSS statistical 
software. The clinicians using these laboratories at the time 
relied on clinical breast examinations (CBE) for their 
diagnoses, occasionally employing the use of ultra-sound 
scan. At the time of data collection, there was no 
mammography in any of the health centres studied. In this 
study, histopathologic diagnoses were solely based on 
histology and histochemical techniques. Laboratory request 
forms on which the clinical diagnoses were omitted by the 
clinicians are recorded as “no cancer” diagnoses by the 
authors. 
Inclusion criterion 
Results of all properly sampled and labelled 
open-breast-biopsy specimens submitted by registered 
physicians were included in the study. 
Exclusion criteria 
1. Results of breast specimens other than that acquired by 
open-breast-biopsy.  
2. Results of non-breast biopsy specimens.   
3. Breast specimens considered inadequate for histologic 
evaluation are excluded from the study. 
4. Autolysed specimens are excluded. 
5. Mislabelled specimens are also excluded. 
Tables 1, 2 and 3 present clinical diagnostic data for 
malignant breast lesion for a sample of subjects who 
presented to both public and private hospitals in Anambra 
State Nigeria. 
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Here the histologic diagnoses is considered the reference 
(gold) standard, hence it stands as the state of nature or the 
true state of condition; while clinical diagnoses, which 
accuracy is to be tested, are the provisional diagnoses as 
reported by various clinicians who examined the patients. 
The following were consequently obtained and used in the 
study. 
 Data Analysis 
Applying the formulations in Oyeka et al (2013) [18] to the 
screening data in Tables 1, 2 and 3, we obtained the estimates 
of rates shown in Table 4. 
 






All Hospitals  
Public Hospitals 
Private Hospitals 
Sensitivity (   e) 0.69193 0.82857 0.57492 
Specificity (      0.08582 0.14315 0.05996 
False positive rate (      ) 0.99075 0.99326 0.98894 
False negative rate (     ) 0.00039 0.00023 0.00052 
Odds of positive response (   ) 0.00934 0.00679 0.01118 
Odds of negative response (    ) 0.00039 0.00023 0.00052 
Odds ratio (   ) 23.94871 29.52173  21.50000  
 
Results 
From Table 4 it is seen that the sensitivity and specificity of 
the screening test are respectively 82,857 and 14,315 per 
100,000 for public hospitals and 57,492 and 5,996 per 
100,000 patients for private hospitals. Thus the diagnostic 
screening test is more sensitive but less specific in public 
hospitals than in private hospitals. 
For all hospitals combined the false positive rate is 
estimated as 0.99075. It is estimated to be 0.99326 in public 
and 0.98894 in private hospitals respectively. Thus for every 
100,000 patients screened in public hospitals and found to 
test positive for breast cancer 99,326 are actually free of the 
disease compared with 98,894 for private hospital, a relative 
difference of 432 per 100,000 in favour of private hospitals 
in being better able to make more accurate diagnoses. The 
true positive rates for public and private hospitals are 
respectively 0.00674 and 0.00112, giving an overall true 
positive rate of 0.00925. In other words for every 100,000 
patients clinically diagnosed as having breast cancer only 
674 and 112 actually have the malignancy in public and 
private hospitals respectively, giving an overall true positive 
rate of 925 per 100,000. 
Similarly the estimated false negative rate for all hospitals 
is 0.00039. It is estimated to be 0.00023 and 0.00052 in 
public and private hospitals respectively. Thus for every 
100,000 patients diagnosed and found to be free of breast 
cancer in public and private hospitals, 23 and 52 patients 
respectively actually have breast cancer giving an overall 
misdiagnoses rate of 39 per 100,000 patients that should 
have been so  informed that they have breast cancer. The 
overall true negative rate for all hospitals is therefore 99,961 
per 100,000 cases. The error in breast cancer diagnoses 
seems more attributable to private than to public hospitals. 
The odds of positive response is 0.00934 for all hospitals 
combined; while it is 0.00679 and 0.01118 for public and 
private hospitals respectively. In other words among those 
testing positive to breast cancer, these estimated rates show 
that for every 100,000 patients who are diagnosed as having 
breast cancer 934, 679 and 1,118 patients are confirmed to 
actually have the disease by clinical diagnoses in all the 
hospitals combined, public and private hospitals respectively. 
Or more specifically, for every 100,000 patients who are 
actually free of breast cancer among those screened and 
found to have the disease, 934, 679 and 1,118 actually have 
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the disease if screened by all hospitals combined, public and 
private hospitals respectively. There is thus a relative 
difference of 439 per 100,000 in better diagnostic accuracy in 
favour of private hospitals over public hospitals.   
Note that the estimated odds of negative response 
indicates that for every 100,000 cases that actually have 
breast cancer among those tested and found not to have the 
disease, about 39, 23 and 52 respectively actually have breast 
cancer if screened by all hospitals combined, public and 
private hospitals respectively. 
Finally, the resulting odds ratios are found to be 23.94871, 
29.52173 and 21.50000 for all hospitals combined, public 
and private hospitals respectively. This means that for every 
one patient incorrectly diagnosed as not having breast cancer 
there are about 30 breast cancer patients who are correctly 
diagnosed as having the disease if diagnoses is by public 
hospitals and about 22 breast cancer patients correctly 
diagnosed if diagnoses is by private hospitals, giving an 
overall rate of about 24 breast cancer patients correctly 
diagnosed as having the disease for every breast cancer 
patient incorrectly diagnosed in all hospitals. 
Although there is significant positive association between 
clinical diagnoses and histologic diagnoses of breast lesions 
(the calculated chi-square values, using the usual chi-square 
test for independence, are 350.741 for public hospitals and 
452.649 for private hospitals) in all screening centres, there is 
clearly stronger association in public than in private hospitals. 
This is because the relative sizes of the corresponding 
estimated odds ratios indicate that public hospitals are 
probably more efficient than private hospitals in being able to 
more accurately screen and isolate breast cancer cases.    
Discussion   
Our data showed that the combined breast cancer diagnostic 
sensitivity for all hospital groups is about 69%. This low 
overall sensitivity probably may be partly attributable to the 
rather low sensitivity in the private hospital group and partly 
due to the high submission of “no clinical diagnoses” by the 
doctors requesting histopathology investigation. We found 
that 459(21%) of the submitted histopathology request forms 
lacked provisional (clinical) diagnoses (not shown in the 
table). This frequency of inadequate completion of 
laboratory request forms has early been noted by Onyiaorah 
et al (2012) [23]. It would be instructive to further explore the 
reason(s) for such omission to know which is specifically 
due to lack of knowledge of the diagnoses and those that are 
truly unwitting omissions. The clinical diagnoses of breast 
lesions by doctors working in public hospitals is about 26% 
more sensitive than that of doctors working in private 
hospitals, which probably explains why public hospitals are 
able to more accurately screen and isolate true breast cancer 
cases than private hospitals. This is probably due to higher 
number of better trained and more experienced doctors in the 
workforce of the public hospitals in the state than that in the 
private hospital group.  Another probable reason for the 
higher sensitivity recorded by doctors in public hospitals is 
that these doctors are more likely to abide by established 
diagnostic protocol and quality management system as may 
be adopted by their units and/or hospitals. Moreover, the 
doctors in public hospitals often have the benefit of case peer 
review and this probably may have enhanced the sensitivity 
of their diagnoses of breast lesions. 
The specificity seen in all hospital groups is low. This 
would probably have been higher if modern radiodiagnostic 
techniques were available and in use in these health centres. 
Majid et al (2003) demonstrated the ability of 
mammography to enhance the accuracy of breast cancer 
screening [10]. 
The false positive rate is found to be fairly high in both 
hospital groups. This may have caused some psycho-social 
trauma to the otherwise cancer-free patients as noted by Fang 
et al (2012) [16]. This underscores the need to have an 
efficient histopathology unit to quickly and more accurately 
disprove or confirm the diagnoses. Hence the Australian 
cancer network (2001) stated that treatment of cancer will 
depend on histologic diagnosis rather that clinical diagnosis 
[7]. The false negative rate are respectively 23 and 52 per 
100,000 patients for public and private hospitals. These are 
better than the false negative rate of 190 per 100,000 
recorded for screening by CBE in a case series by Day et al 
(1990) [11]. 
Conclusion 
Our findings brought to the fore the need for more funding of 
our health system. Regular training and re-training of the 
country’s medical personnel and infrastructural development 
of the hospitals may probably enable better accuracy in 
breast cancer diagnoses. 
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